AB 1864: Gene synthesis equipment manufacturers and providers.

Official summary

Legislative Counsel’s Digest (official, as of the latest version). Written by nonpartisan legislative staff; reproduced verbatim.

Existing law requires the State Department of Public Health to establish an advisory committee to advise the Legislature and the Governor on human cloning and other issues relating to human biotechnology. Existing law requires the California State University, and requests the University of California, to develop systemwide guidance for purchasing gene synthesis equipment or gene synthesis products from gene synthesis providers who prevent the misuse of synthetic genes and safeguard the benefits of gene synthesis technology while minimizing risk, as specified.

This bill would prohibit a manufacturer of benchtop nucleic acid synthesis equipment, as defined, from producing equipment in this state or selling or delivering that equipment to a customer in this state unless the manufacturer adheres to the Framework for Nucleic Acid Synthesis Screening issued by the Fast Track Action Committee on Synthetic Nucleic Acid Procurement Screening of the National Science and Technology Council, as revised in September 2024, with respect to that equipment, attests that they comply with the framework with respect to that equipment, and posts that attestation on a public internet website, and would prohibit a provider of specified synthetic nucleic acids from producing those nucleic acids in this state or selling or delivering those nucleic acids to a customer in this state unless the provider adheres to the framework described above with respect to those nucleic acids, attests to complying with the framework with respect to those nucleic acids, and posts that attestation on a public internet website. The bill would make a violation of the prohibitions described above subject to a civil penalty in an amount dependent on the severity of the violation that does not exceed $5,000 per day that the violation continues. The bill would make related findings and declarations.

This bill would provide that the provisions of this bill are severable.

Sponsors

Sponsors by party (alphabetical): Democratic 1

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

1. September 30, 2026Chaptered by Secretary of State - Chapter 852, Statutes of 2026.
2. September 30, 2026Approved by the Governor.
3. August 27, 2026Enrolled and presented to the Governor at 4 p.m.
4. August 20, 2026Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 77. Noes 0. Page 6321.).
5. August 19, 2026In Assembly. Concurrence in Senate amendments pending.
6. August 19, 2026Read third time. Passed. Ordered to the Assembly. (Ayes 37. Noes 0.).
7. August 17, 2026Read second time. Ordered to third reading.
8. August 13, 2026Read second time and amended. Ordered returned to second reading.
9. August 13, 2026From committee: Amend, and do pass as amended. (Ayes 7. Noes 0.) (August 13).
10. August 3, 2026In committee: Referred to APPR. suspense file.
11. June 24, 2026From committee: Do pass and re-refer to Com. on APPR. with recommendation: To Consent Calendar. (Ayes 13. Noes 0.) (June 23). Re-referred to Com. on APPR.
12. June 11, 2026From committee: Do pass and re-refer to Com. on JUD. with recommendation: To Consent Calendar. (Ayes 10. Noes 0.) (June 10). Re-referred to Com. on JUD.